Results 251 to 260 of about 240,256 (373)

The Persistence of Dopamine Dysregulation Syndrome after Pallidal Deep Brain Stimulation in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Dopamine dysregulation syndrome (DDS) is a debilitating complication of Parkinson's disease (PD) dopamine replacement therapy (DRT) in which patients pathologically and/or compulsively use dopaminergic drugs to treat motor symptoms. Studies examining DDS outcomes following deep brain stimulation (DBS) are limited and have focused on
Natalie David, Stewart A. Factor, Richa Tripathi, Lenora Higginbotham   +3 more
wiley   +1 more source

Olfactory Dysfunction in a Novel Model of Prodromal Parkinson's Disease in Adult Zebrafish. [PDF]

Int J Mol Sci
Vorhees NW, Groenwold SL, Williams MT, Putt LS, Sanchez-Gama N, Stalions GA, Taylor GM, Van Dort HE, Calvo-Ochoa E.   +8 more
europepmc   +1 more source

Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice

, 1989
Isao Date, Suzanne Y. Felten, David L. Felten   +2 more
openalex   +1 more source

Health‐Related Quality of Life in Relation to the 5‐2‐1 Criteria in Parkinson's Disease in Sweden

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Device‐aided therapies (DAT) offer alternatives to oral or transdermal dopaminergic treatments in advanced Parkinson's disease (PD), where they can reduce motor fluctuations and dyskinesia and improve health‐related quality of life (HRQoL).
Frida Hjalte, Anna Gustafsson, Jenny Samuelsson, Filip Bergquist, Anders Johansson, Per Odin   +5 more
wiley   +1 more source

Motor asymmetry in Parkinson's disease: Diagnostic thresholds based on clinical scores and DaTSCAN imaging. [PDF]

Clin Park Relat Disord
Voruz P, Péron J.
europepmc   +1 more source

Evidence for endogenous dopaminergic regulation of thyrotropin (TSH) secretion in man.

, 1983
Atsushi Sasaki, Kunihiko Hanew, Shuichi Sato, KAORU YOSHINAGA   +3 more
openalex   +2 more sources

Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Swallowing disorders are prevalent in Parkinson's disease (PD). Swallowing assessment often relies on patient‐reported outcome measures (PROMs). Although PROMs and physiologic swallowing measures correlate with disease severity, the relationship between PROMs and physiologic swallowing impairments is unclear.
Rabab Rangwala, Mariana Mendes Bahia, Jing Song, Danny Bega, Bonnie Martin‐Harris   +4 more
wiley   +1 more source

Therapeutic Mechanisms of Exercise in Parkinson's Disease. [PDF]

Int J Mol Sci
Wilson AC, Pountney DL, Khoo TK.
europepmc   +1 more source

TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice.

, 1985
Masaomi Miyamoto, Yoshiaki Saji, Yuji Nagawa   +2 more
openalex   +2 more sources

Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson's disease models via PMK-1/p38 MAPK and SKN-1/Nrf2 signaling. [PDF]

Sci Rep
Francisco M, Grau R.
europepmc   +1 more source